secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001104659-24-068733
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics replaces auditor Mazars with Forvis Mazars effective June 1, 2024
--------------------------------------------------------------------------------

- Mazars USA LLP resigned after its partners and employees joined FORVIS LLP; the combined firm is now Forvis Mazars LLP.
- No adverse opinions, disagreements, or reportable events occurred in fiscal years 2022 or 2023 during Mazars' tenure.
- Audit committee appointed Forvis Mazars as new independent registered public accounting firm, subject to stockholder ratification.
- Mazars' letter to the SEC regarding the change is filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/0001104659-24-068733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/tm2416518d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer